Table 3 Comparison of risk factors in Stanford type B patients with or without complications.

From: Comparative study on clinical efficacy of different methods for the treatment of intramural aortic hematoma

Risk factor

Complications (35)

No complications (85)

Total (n = 120)

P

Male

20 (57.14)

58 (68.24)

78 (65)

0.7

Female

15 (42.86)

27 (31.76)

42 (35)

0.65

Age

65.1 ± 5.2

62.8 ± 6.3

63.9 ± 10.4

0.85

Hypertension

27 (77.14)

71 (83.53)

98 (81.67)

0.13

Delayed diagnosis (h)

8.5 ± 2.0

8.9 ± 3.5

8.8 ± 3.0

0.42

History of smoking

16 (45.71)

15 (17.65)

31 (25.83)

0.021

Diabetes

1 (2.86)

1 (1.18)

2

Heart disease

3 (8.57)

3 (3.53)

6

Focal intimal rupture

5 (14.28)

4 (4.71)

9

0.012

Thoracic or pericardial effusion

12 (34.29)

20 (23.53)

32

0.030

Haematoma thickness ≥ 11 mm

15 (42.86)

1 (1.18)

16

0.001

Maximum aortic diameter ≥ 50 mm

12 (34.29)

2 (2.35)

14

0.001